BioStem Technologies, Inc. (OTCMKTS:BSEM) Short Interest Up 25.7% in July

BioStem Technologies, Inc. (OTCMKTS:BSEM) was the recipient of a large growth in short interest during the month of July. As of July 31st, there was short interest totalling 63,500 shares, a growth of 25.7% from the July 15th total of 50,500 shares. Based on an average daily trading volume, of 35,700 shares, the short-interest ratio is presently 1.8 days.

BioStem Technologies Stock Performance

BSEM traded down 0.63 during mid-day trading on Friday, reaching 11.99. The stock had a trading volume of 51,200 shares, compared to its average volume of 26,461. The stock has a market capitalization of $195.29 million, a P/E ratio of 32.05 and a beta of 0.03. BioStem Technologies has a 52 week low of 1.21 and a 52 week high of 15.50. The firm’s fifty day simple moving average is 9.16 and its two-hundred day simple moving average is 9.29.

BioStem Technologies (OTCMKTS:BSEM) last posted its quarterly earnings results on Monday, August 12th. The company reported 0.30 earnings per share for the quarter, topping the consensus estimate of 0.12 by 0.18. The firm had revenue of 74.49 million for the quarter, compared to the consensus estimate of 43.99 million. As a group, analysts expect that BioStem Technologies will post 0.49 EPS for the current fiscal year.

About BioStem Technologies

BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.